Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 05-Mar-24 4:07 PM View:  | Apellis Pharmaceuticals, Inc. (APLS) | 01-Mar-24 | Option Exercise | 250,000 | $4.20 | $1,050,000.00 | 12% 2.04M to 2.29M | |
| 05-Mar-24 4:07 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Mar-24 | Option Sale | 250,000 | $64.11 | $16,028,700.00 | (11%) 2.29M to 2.04M | |
| 13-Feb-24 4:49 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 12-Feb-24 | Private Sale | 3,962 | $67.77 | $268,492.00 | (< 1%) 2.04M to 2.04M | |
| 31-Jan-24 4:26 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 29-Jan-24 | Private Sale | 2,843 | $64.14 | $182,345.00 | (< 1%) 2.04M to 2.04M | |
| 23-Jan-24 7:28 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 22-Jan-24 | Private Sale | 13,431 | $65.00 | $872,961.00 | (< 1%) 2.06M to 2.04M | |
| 17-Jan-24 4:32 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-Jan-24 | Grant | 72,094 | -- | -- | 4% 1.99M to 2.06M | |
| 17-Jan-24 4:32 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-Jan-24 | Sale | 7,851 | $66.81 | $524,514.00 | (< 1%) 2.06M to 2.06M | |
| 21-Nov-23 5:36 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Nov-23 | Private Sale | 5,000 | $48.80 | $244,000.00 | (< 1%) 2.0M to 1.99M | |
| 20-Sep-23 4:26 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 19-Sep-23 | Gift | 150,000 | -- | -- | 8% 2.0M to 2.15M | |
| 20-Sep-23 4:26 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 19-Sep-23 | Gift | 150,000 | -- | -- | (7%) 2.15M to 2.0M | |
| 01-Sep-23 4:05 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Sep-23 | Option Exercise | 300,000 | $2.67 | $801,000.00 | 16% 1.85M to 2.15M | |
| 01-Sep-23 4:05 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Sep-23 | Option Sale | 150,000 | $41.75 | $6,262,960.00 | (7%) 2.15M to 2.0M | |
| 25-May-23 4:44 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 24-May-23 | Gift | 20,000 | -- | -- | 1% 1.85M to 1.87M | |
| 25-May-23 4:44 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 24-May-23 | Gift | 20,000 | -- | -- | (1%) 1.87M to 1.85M | |
| 18-May-23 5:10 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 17-May-23 | Option Exercise | 20,000 | $2.67 | $53,400.00 | 1% 1.83M to 1.85M | |
| 18-May-23 5:10 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-May-23 | Option Exercise | 30,000 | $2.67 | $80,100.00 | 2% 1.83M to 1.86M | |
| 18-May-23 5:10 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-May-23 | Planned Option Sale | 30,000 | $85.66 | $2,569,900.00 | (2%) 1.86M to 1.83M | |
| 28-Apr-23 4:15 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 27-Apr-23 | Gift | 382,946 | -- | -- | 21% 1.83M to 2.21M | |
| 28-Apr-23 4:15 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 27-Apr-23 | Gift | 382,946 | -- | -- | (17%) 2.21M to 1.83M | |
| 20-Apr-23 4:51 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 19-Apr-23 | Option Exercise | 20,000 | $2.67 | $53,400.00 | 1% 1.81M to 1.83M | |
| 20-Apr-23 4:51 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 18-Apr-23 | Option Exercise | 30,000 | $2.67 | $80,100.00 | 2% 1.81M to 1.84M | |
| 20-Apr-23 4:51 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 18-Apr-23 | Planned Option Sale | 30,000 | $82.02 | $2,460,720.00 | (2%) 1.84M to 1.81M | |
| 05-Apr-23 5:56 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 05-Apr-23 | Gift | 26,990 | -- | -- | 1% 1.81M to 1.83M | |
| 05-Apr-23 5:56 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 05-Apr-23 | Gift | 26,990 | -- | -- | (1%) 1.83M to 1.81M | |
| 05-Apr-23 5:56 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 04-Apr-23 | Gift | 380,000 | -- | -- | 21% 1.81M to 2.19M | |
| 05-Apr-23 5:56 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 04-Apr-23 | Gift | 380,000 | -- | -- | (17%) 2.19M to 1.81M | |
| 05-Apr-23 5:56 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-Apr-23 | Gift | 227,221 | -- | -- | 13% 1.81M to 2.03M | |
| 05-Apr-23 5:56 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-Apr-23 | Gift | 227,221 | -- | -- | (11%) 2.03M to 1.81M | |
| 23-Mar-23 4:55 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 22-Mar-23 | Option Exercise | 107,221 | $4.44 | $476,011.00 | 6% 1.68M to 1.79M | |
| 23-Mar-23 4:55 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 22-Mar-23 | Option Exercise | 20,000 | $2.67 | $53,400.00 | 1% 1.79M to 1.81M | |
| 23-Mar-23 4:55 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Mar-23 | Option Exercise | 30,000 | $2.67 | $80,100.00 | 2% 1.68M to 1.71M | |
| 23-Mar-23 4:55 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Mar-23 | Planned Option Sale | 30,000 | $62.74 | $1,882,330.00 | (2%) 1.71M to 1.68M | |
| 01-Mar-23 4:10 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 27-Feb-23 | Option Exercise | 100,000 | $3.76 | $376,000.00 | 6% 1.58M to 1.68M | |
| 22-Feb-23 6:40 AM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Feb-23 | Grant | 13,908 | -- | -- | < 1% 1.57M to 1.58M | |
| 22-Feb-23 6:40 AM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Feb-23 | Payment of Exercise | 1,602 | $58.50 | $93,717.00 | (< 1%) 1.58M to 1.58M | |
| 14-Feb-23 4:42 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Feb-23 | Payment of Exercise | 3,958 | $51.21 | $202,689.00 | (< 1%) 1.57M to 1.57M | |
| 30-Jan-23 4:59 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 27-Jan-23 | Payment of Exercise | 2,879 | $52.77 | $151,925.00 | (< 1%) 1.57M to 1.57M | |
| 24-Jan-23 5:17 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 20-Jan-23 | Payment of Exercise | 9,453 | $52.05 | $492,029.00 | (< 1%) 1.58M to 1.57M | |
| 17-Jan-23 7:37 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 12-Jan-23 | Grant | 83,447 | -- | -- | 6% 1.5M to 1.58M | |
| 21-Dec-22 4:13 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 19-Dec-22 | Option Exercise | 21,688 | $7.21 | $156,386.00 | 1% 1.48M to 1.5M | |
| 21-Dec-22 4:13 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 19-Dec-22 | Option Exercise | 28,200 | $2.67 | $75,294.00 | 2% 1.5M to 1.53M | |
| 21-Dec-22 4:13 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 19-Dec-22 | Planned Option Sale | 28,200 | $52.06 | $1,467,980.00 | (2%) 1.53M to 1.5M | |
| 21-Dec-22 4:13 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 25-Apr-22 | Disposition (other) | 12,500 | -- | -- | (< 1%) 1.49M to 1.48M | |
| 14-Feb-22 6:20 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Feb-22 | Payment of Exercise | 2,523 | $47.12 | $118,884.00 | (< 1%) 1.49M to 1.49M | |
| 01-Feb-22 6:00 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 28-Jan-22 | Payment of Exercise | 2,024 | $38.59 | $78,106.20 | (< 1%) 1.57M to 1.57M | (15%) |
| 25-Jan-22 4:58 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Jan-22 | Grant | 106,244 | -- | -- | 7% 1.47M to 1.57M | |
| 22-Jul-21 4:04 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Jul-21 | Option Exercise | 14,410 | $4.31 | $62,107.10 | < 1% 1.45M to 1.47M | |
| 10-Feb-22 10:00 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-Jun-21 | Gift | 80,000 | -- | -- | (5%) 1.47M to 1.39M | |
| 11-Feb-21 4:05 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Feb-21 | Payment of Exercise | 2,523 | $47.72 | $120,398.00 | (< 1%) 1.46M to 1.45M | (19%) |
| 01-Feb-21 4:42 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 28-Jan-21 | Grant | 37,500 | -- | -- | 3% 1.42M to 1.46M |